Cargando…

Native envelope-based immunogens derived from critical timepoints in the development of breadth elicit rapid neutralizing antibodies in rabbits

Detalles Bibliográficos
Autores principales:	Malherbe, DC, Hessell, AJ, Sather, ND, Guo, B, Pandey, S, Pissani, F, Robins, H, Kalams, S, Stamatatos, L, Haigwood, NL
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441366/ http://dx.doi.org/10.1186/1742-4690-9-S2-P345

Ejemplares similares

P05-10. Sequential immunization with a subtype B HIV-1 envelope quasispecies elicits broader neutralization than vaccination with a single envelope clone
por: Malherbe, DC, et al.
Publicado: (2009)

Rapid Induction of Multifunctional Antibodies in Rabbits and Macaques by Clade C HIV-1 CAP257 Envelopes Circulating During Epitope-Specific Neutralization Breadth Development
por: Malherbe, Delphine C., et al.
Publicado: (2020)

Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth
por: Chukwuma, Valentine U., et al.
Publicado: (2018)

Soluble HIV-1 Envelope Immunogens Derived from an Elite Neutralizer Elicit Cross-Reactive V1V2 Antibodies and Low Potency Neutralizing Antibodies
por: Carbonetti, Sara, et al.
Publicado: (2014)

P04-15. Prevalence of broadly neutralizing antibody responses during acute/early HIV infection
por: Mikell, I, et al.
Publicado: (2009)

Biodistribution of neutralizing monoclonal antibodies IgG1 b12 and LALA in mucosal and lymphatic tissues of rhesus macaques
por: Hessell, AJ, et al.
Publicado: (2012)

Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1
por: Mikell, Iliyana, et al.
Publicado: (2011)

Correction: Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1
por: Mikell, Iliyana, et al.
Publicado: (2011)

P19-06. The first hypervariable loop and HIV-1 neutralizing antibodies elicited by gp140 env immunogens
por: Ching, LK, et al.
Publicado: (2009)

Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization
por: Turner, Hannah L., et al.
Publicado: (2021)

Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization
por: Turner, Hannah L., et al.
Publicado: (2021)

Star nanoparticles delivering HIV-1 peptide minimal immunogens elicit near-native envelope antibody responses in nonhuman primates
por: Francica, Joseph R., et al.
Publicado: (2019)

Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth
por: Wagh, Kshitij, et al.
Publicado: (2018)

HIV envelope antigen valency on peptide nanofibers modulates antibody magnitude and binding breadth
por: Fries, Chelsea N., et al.
Publicado: (2021)

Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates
por: Cottrell, Christopher A., et al.
Publicado: (2020)

HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth
por: van Schooten, Jelle, et al.
Publicado: (2018)

Multiomics single timepoint measurements to predict severe COVID-19
por: Tegethoff, Sina A, et al.
Publicado: (2023)

Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization
por: Torrents de la Peña, Alba, et al.
Publicado: (2017)

HIV-1 Envelope Glycoprotein Resistance to Monoclonal Antibody 2G12 Is Subject-Specific and Context-Dependent in Macaques and Humans
por: Malherbe, Delphine C., et al.
Publicado: (2013)

Single-Timepoint Snapshot of Hemoglobin: Is it Enough to Reflect the Dynamicity of Coronary Atherosclerosis?
por: Yang, Seokhun, et al.
Publicado: (2022)

Changes to Astrocyte-associated Protein Expression at Different Timepoints of Cuprizone Treatment
por: Frankle, Lana, et al.
Publicado: (2023)

Key correlates of exclusive breastfeeding at three timepoints: Evidence from Ethiopia
por: Yigletu, Seblewongel, et al.
Publicado: (2022)

P19-42. Engineering, expression and antigenic and immunogenic characterization of novel soluble clade A/B heterotrimeric gp140-envelope glycoproteins
por: Sellhon, G, et al.
Publicado: (2009)

Fine epitope signature of antibody neutralization breadth at the HIV-1 envelope CD4-binding site
por: Cheng, Hao D., et al.
Publicado: (2018)

B cell clonal lineage alterations upon recombinant HIV-1 envelope immunization of rhesus macaques
por: Yacoob, Christina, et al.
Publicado: (2018)

P05-12. A computationally designed immunogen elicits potent anti-V3 neutralizing antibodies
por: Carrico, CT, et al.
Publicado: (2009)

The Breadth of Black
Publicado: (1871)

Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic
por: Spencer, David A., et al.
Publicado: (2021)

Protein Nanoparticle-Mediated Delivery of Recombinant Influenza Hemagglutinin Enhances Immunogenicity and Breadth of the Antibody Response
por: Badten, Alexander J., et al.
Publicado: (2023)

P09-06. HIV-1 escape from broadly neutralizing anti-CD4 binding site NAbs during HIV-1 infection
por: Sather, D, et al.
Publicado: (2009)

AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease
por: Molinari, Paolo, et al.
Publicado: (2021)

Multiomics single timepoint measurements to predict severe COVID-19 – Authors' reply
por: Garapati, Kishore, et al.
Publicado: (2023)

Leveraging the Clinical Timepoints in Lung Cancer Screening to Engage Individuals in Tobacco Treatment
por: Park, Elyse R, et al.
Publicado: (2022)

Neuropsychological predictors of conversion from mild cognitive impairment to dementia at different timepoints
por: Quaranta, Davide, et al.
Publicado: (2023)

Tetravalent Immunogen Assembled from Conserved Regions of HIV-1 and Delivered as mRNA Demonstrates Potent Preclinical T-Cell Immunogenicity and Breadth
por: Moyo, Nathifa, et al.
Publicado: (2020)

Identification of a clade A HIV envelope immunogen from Protocol G that elicits neutralizing antibodies to tier 2 viruses
por: Hoffenberg, S, et al.
Publicado: (2012)

Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity
por: Sliepen, Kwinten, et al.
Publicado: (2015)

Breadth in contemporary topology
por: Gay, David T, et al.
Publicado: (2019)

AJRCCM: Strength in Breadth
por: Bush, Andrew, et al.
Publicado: (2023)

Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
por: Hoot, Sam, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_a54thsgrvue1fuvuqq9c8tsuuh